shutterstock_1179311608_vchal

vchal / Shutterstock.com

20 July 2023Big PharmaLiz Hockley

US appeals court restores five CRISPR patents with precedential opinion on interferences

SNIPR Biome has five patents reinstated after court rules they cannot be subject to interference | Rockefeller University had challenged patents on pre-AIA, first-to-invent basis.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Biotech secures CRISPR patent for COVID-19 diagnostic test

21 February 2023 Sherlock boosts IP portfolio with exclusive US rights to patent | Technology could be used to detect malaria, TB and COVID-19.

USPTO rules Broad owns CRISPR animal cell editing patents

1 March 2022 Patents core to the breakthrough gene-editing technology CRISPR belong to the University of Harvard and the Massachusetts Institute of Technology’s Broad Institute, the US Patent and Trademark Office has ruled.

More on this story

USPTO rules Broad owns CRISPR animal cell editing patents

1 March 2022 Patents core to the breakthrough gene-editing technology CRISPR belong to the University of Harvard and the Massachusetts Institute of Technology’s Broad Institute, the US Patent and Trademark Office has ruled.

Biotechnology

Biotech secures CRISPR patent for COVID-19 diagnostic test

21 February 2023 Sherlock boosts IP portfolio with exclusive US rights to patent | Technology could be used to detect malaria, TB and COVID-19.

More on this story

USPTO rules Broad owns CRISPR animal cell editing patents

1 March 2022 Patents core to the breakthrough gene-editing technology CRISPR belong to the University of Harvard and the Massachusetts Institute of Technology’s Broad Institute, the US Patent and Trademark Office has ruled.

Biotechnology

Biotech secures CRISPR patent for COVID-19 diagnostic test

21 February 2023 Sherlock boosts IP portfolio with exclusive US rights to patent | Technology could be used to detect malaria, TB and COVID-19.

More features

Fed Circ orders Teva to delist five patents from Orange Book

Sarepta wins $115M in patent dispute over muscular dystrophy drug

Novartis shields eye-drop patent at European Patent Office

CREATES Act unfairly tips the scales to generics

LSPN launches its first-ever US awards to celebrate life sciences leaders

Pharma giants seek closure on COVID-19 vaccine rows

How Inhibrx defended a $450m damages suit

Foley & Lardner adds litigation and transaction expert in New York